Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-25

FDA Approved: EZALLOR SPRINKLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's supplemental application for EZALLOR SPRINKLE (rosuvastatin), adding a sprinkle formulation to the rosuvastatin product line t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZALLOR SPRINKLE (ROSUVASTATIN)

Snippet

SUPPL AP for EZALLOR SPRINKLE (ROSUVASTATIN)